• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

密歇根州前列腺癌治疗决策辅助工具的实施:一项定性研究。

Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study.

作者信息

Paudel Roshan, Ferrante Stephanie, Woodford Jessica, Maitland Conrad, Stockall Eric, Maatman Thomas, Lane Giulia I, Berry Donna L, Sales Anne E, Montie James E

机构信息

Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, USA.

Michigan Urological Surgery Improvement Collaborative, University of Michigan, Ann Arbor, MI, USA.

出版信息

Implement Sci Commun. 2021 Mar 6;2(1):27. doi: 10.1186/s43058-021-00125-w.

DOI:10.1186/s43058-021-00125-w
PMID:33676583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7936475/
Abstract

BACKGROUND

The American Urological Association White Paper on Implementation of Shared Decision Making (SDM) into Urological Practice suggested SDM represents the state of the art in counseling for patients who are faced with difficult or uncertain medical decisions. The Michigan Urological Surgery Improvement Collaborative (MUSIC) implemented a decision aid, Personal Patient Profile-Prostate (P3P), in 2018 to help newly diagnosed prostate cancer patients make shared decisions with their clinicians. We conducted a qualitative study to assess statewide implementation of P3P throughout MUSIC.

METHODS

We recruited urologists and staff from 17 MUSIC practices (8 implementation and 9 comparator practices) to understand how practices engaged patients on treatment discussions and to assess facilitators and barriers to implementing P3P. Interview guides were developed based on the Tailored Interventions for Chronic Disease (TICD) Framework. Interviews were transcribed for analysis and coded independently by two investigators in NVivo, PRO 12. Additionally, quantitative program data were integrated into thematic analyses.

RESULTS

We interviewed 15 urologists and 11 staff from 16 practices. Thematic analysis of interview transcripts indicated three key themes including the following: (i) P3P is compatible as a SDM tool as over 80% of implementation urologists asked patients to complete the P3P questionnaire routinely and used P3P reports during treatment discussions; (ii) patient receptivity was demonstrated by 370 (50%) of newly diagnosed patients (n = 737) from 8 practices enrolled in P3P with 78% completion rate, which accounts for 39% of all newly diagnosed patients in these practices; and (iii) urologists' attitudes towards SDM varied. Over a third of urologists stated they did not rely on a decision aid. Comparator practices indicated habit, inertia, or concerns about clinic flow as reasons for not adopting P3P and some were unconvinced a decision aid is needed in their practice.

CONCLUSION

Urologists and staff affiliated with MUSIC implementation sites indicated that P3P focuses the treatment discussion on items that are important to patients. Experiences of implementation practices indicate that once initiated, there were no negative effects on clinic flow and urologists indicated P3P saves time during patient counseling, as patients were better prepared for focused discussions. Lack of awareness, personal habits, and inertia are reasons for not implementing P3P among the comparator practices.

摘要

背景

美国泌尿外科学会关于在泌尿外科实践中实施共同决策(SDM)的白皮书指出,对于面临困难或不确定医疗决策的患者,共同决策代表了咨询方面的最新技术水平。密歇根泌尿外科手术改进协作组织(MUSIC)在2018年实施了一项决策辅助工具,即个人患者档案-前列腺(P3P),以帮助新诊断的前列腺癌患者与临床医生进行共同决策。我们进行了一项定性研究,以评估P3P在整个MUSIC中的全州实施情况。

方法

我们从17个MUSIC医疗机构(8个实施机构和9个对照机构)招募了泌尿科医生和工作人员,以了解这些机构如何让患者参与治疗讨论,并评估实施P3P的促进因素和障碍。访谈指南是根据慢性病定制干预(TICD)框架制定的。访谈内容被转录用于分析,并由两名研究人员在NVivo PRO 12中独立编码。此外,定量项目数据被纳入主题分析。

结果

我们采访了来自16个机构的15名泌尿科医生和11名工作人员。访谈记录的主题分析表明有三个关键主题,包括:(i)P3P作为一种共同决策工具是合适的,因为超过80%的实施机构的泌尿科医生常规要求患者填写P3P问卷,并在治疗讨论中使用P3P报告;(ii)来自8个参与P3P的机构的370名(50%)新诊断患者(n = 737)表现出患者接受度,完成率为78%,占这些机构所有新诊断患者的39%;(iii)泌尿科医生对共同决策的态度各不相同。超过三分之一的泌尿科医生表示他们不依赖决策辅助工具。对照机构表示习惯、惰性或对诊所流程有担忧是不采用P3P的原因,一些人不相信他们的实践中需要决策辅助工具。

结论

与MUSIC实施机构相关的泌尿科医生和工作人员表示,P3P将治疗讨论聚焦于对患者重要的项目上。实施机构的经验表明,一旦启动,对诊所流程没有负面影响,泌尿科医生表示P3P在患者咨询期间节省了时间,因为患者为有重点的讨论做好了更好的准备。缺乏认识、个人习惯和惰性是对照机构中不实施P3P的原因。

相似文献

1
Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study.密歇根州前列腺癌治疗决策辅助工具的实施:一项定性研究。
Implement Sci Commun. 2021 Mar 6;2(1):27. doi: 10.1186/s43058-021-00125-w.
2
Factors Associated with Decision Aid Use in Localized Prostate Cancer.局限性前列腺癌中与决策辅助工具使用相关的因素
Urol Pract. 2022 Jan;9(1):108-115. doi: 10.1097/upj.0000000000000283. Epub 2022 Jan 1.
3
Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.个人患者档案-前列腺(P3P)的开发与评估,这是一个针对新诊断为局限性前列腺癌的男性的基于网络的决策支持系统。
J Med Internet Res. 2010 Dec 17;12(4):e67. doi: 10.2196/jmir.1576.
4
Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients.泌尿科医生对新诊断前列腺癌患者中导致治疗决策的对话因素的看法。
J Cancer Educ. 2017 Sep;32(3):580-588. doi: 10.1007/s13187-016-1025-2.
5
Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.评估决策辅助工具使用对前列腺癌术后患者报告结局的影响。
Urology. 2022 Jul;165:187-192. doi: 10.1016/j.urology.2022.02.008. Epub 2022 Feb 24.
6
Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.为前列腺癌决策制定的准备工作赋值:意愿支付分析。
BMC Med Inform Decis Mak. 2019 Jan 9;19(1):6. doi: 10.1186/s12911-018-0725-4.
7
Adaptation and Implementation of a Shared Decision-Making Tool From One Health Context to Another: Partnership Approach Using Mixed Methods.从一个健康背景到另一个健康背景的共享决策工具的调整和实施:使用混合方法的伙伴关系方法。
J Med Internet Res. 2023 Jul 5;25:e42551. doi: 10.2196/42551.
8
Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.种族/民族差异对前列腺癌治疗选择的影响因素的认可:个人患者特征-前列腺(P3P)I 和 II 试验数据的分析。
Urol Oncol. 2020 Mar;38(3):78.e7-78.e13. doi: 10.1016/j.urolonc.2019.10.015. Epub 2019 Dec 27.
9
Engaging disparities in prostate cancer: Piloting an interactive, virtual workshop to educate providers on shared decision-making for underserved populations.参与式前列腺癌防治差距:试验性互动虚拟研讨会,对服务欠缺人群的共决进行教育。
Urol Oncol. 2023 Oct;41(10):430.e1-430.e7. doi: 10.1016/j.urolonc.2023.06.021. Epub 2023 Jul 13.
10
Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer.我们是否应该更积极地让患者参与进来?多学科团队对转移性去势抵抗性前列腺癌老年患者共同决策的观点。
J Geriatr Oncol. 2019 Jul;10(4):653-658. doi: 10.1016/j.jgo.2018.12.003. Epub 2019 Jan 11.

引用本文的文献

1
Correction: Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study.更正:密歇根州前列腺癌治疗决策辅助工具的实施:一项定性研究。
Implement Sci Commun. 2023 Mar 20;4(1):30. doi: 10.1186/s43058-023-00410-w.
2
Applying the Tailored Implementation in Chronic Diseases framework to inform implementation of the Preferences Elicited and Respected for Seriously Ill Veterans through enhanced decision-making program in the United States Veterans Health Administration.应用慢性病框架中的量身定制实施方法,为美国退伍军人健康管理局通过强化决策项目实施的“重病退伍军人偏好征集与尊重”提供信息支持。
Front Health Serv. 2022 Sep 2;2:935341. doi: 10.3389/frhs.2022.935341. eCollection 2022.
3
Factors Associated with Decision Aid Use in Localized Prostate Cancer.局限性前列腺癌中与决策辅助工具使用相关的因素
Urol Pract. 2022 Jan;9(1):108-115. doi: 10.1097/upj.0000000000000283. Epub 2022 Jan 1.
4
Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.评估决策辅助工具使用对前列腺癌术后患者报告结局的影响。
Urology. 2022 Jul;165:187-192. doi: 10.1016/j.urology.2022.02.008. Epub 2022 Feb 24.
5
Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative.前列腺癌患者的偏好和治疗决策:来自全州范围的泌尿外科质量改进合作的结果。
Urology. 2021 Sep;155:55-61. doi: 10.1016/j.urology.2021.04.020. Epub 2021 Apr 29.

本文引用的文献

1
AUA White Paper on Implementation of Shared Decision Making into Urological Practice.美国泌尿外科学会关于在泌尿外科实践中实施共同决策的白皮书。
Urol Pract. 2016 Sep;3(5):355-363. doi: 10.1016/j.urpr.2015.10.006. Epub 2016 Jun 28.
2
Quality of Care in Urology and the Michigan Urological Surgery Improvement Collaborative.泌尿外科的医疗质量与密歇根泌尿外科手术改进协作组织
Urol Pract. 2014 Jul;1(2):74-78. doi: 10.1016/j.urpr.2014.04.003. Epub 2014 May 1.
3
Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.以患者为中心的偏好评估改善局限性前列腺癌患者的护理满意度:一项随机对照试验。
J Clin Oncol. 2019 Apr 20;37(12):964-973. doi: 10.1200/JCO.18.01091. Epub 2019 Mar 12.
4
Shared decision is the only outcome that matters when it comes to evaluating evidence-based practice.在评估循证实践时,共同决策是唯一重要的结果。
BMJ Evid Based Med. 2018 Aug;23(4):137-139. doi: 10.1136/bmjebm-2018-110922. Epub 2018 Jul 12.
5
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.临床局限性前列腺癌:AUA/ASTRO/SUO 指南。第 I 部分:风险分层、共同决策和治疗选择。
J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15.
6
Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study.老年人癌症化疗和放疗决策体验的定性研究。
J Geriatr Oncol. 2018 Jan;9(1):47-52. doi: 10.1016/j.jgo.2017.07.013. Epub 2017 Aug 19.
7
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.基于个人患者档案——前列腺癌的决策支持:一项多中心随机试验。
J Urol. 2018 Jan;199(1):89-97. doi: 10.1016/j.juro.2017.07.076. Epub 2017 Jul 25.
8
The Tailored Implementation in Chronic Diseases (TICD) project: introduction and main findings.慢性病定制实施(TICD)项目:介绍与主要发现
Implement Sci. 2017 Jan 10;12(1):5. doi: 10.1186/s13012-016-0536-x.
9
Using implementation science to improve urologic oncology care.运用实施科学改善泌尿肿瘤护理。
Urol Oncol. 2016 Sep;34(9):384-7. doi: 10.1016/j.urolonc.2016.05.022. Epub 2016 Jul 9.
10
Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.实际和期望的决策角色与患者报告的护理质量的关联:癌症护理中的共同决策。
JAMA Oncol. 2015 Apr;1(1):50-8. doi: 10.1001/jamaoncol.2014.112.